Title : CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer.

Pub. Date : 2021

PMID : 34335983






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer. Metformin AKT serine/threonine kinase 1 Homo sapiens
2 Finally, we observed that metformin, a new anti-cancer drug, can significantly induce CCDC65 to suppress ENO1-AKT1 complex-mediated cell proliferation and EMT signals and finally suppresses the malignant phenotypes of gastric cancer cells. Metformin AKT serine/threonine kinase 1 Homo sapiens
3 Conclusion: These results firstly highlight a critical role of CCDC65 in suppressing ENO1-AKT1 pathway to reduce the progression of gastric cancer and reveals a new molecular mechanism for metformin in suppressing gastric cancer. Metformin AKT serine/threonine kinase 1 Homo sapiens